Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 12, 2018 08:00 ET | Source: Nemaura Medical Inc

Nemaura to Present SugarBEAT® Clinical Performance Poster at ATTD, Berlin

LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use by...
December 04, 2018 08:00 ET | Source: Nemaura Medical Inc

Nemaura Successfully Completes Clinical Studies for SugarBEAT® FDA De-Novo 510(k) Submission

LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible Continuous Glucose Monitor (CGM) for use by...
November 20, 2018 08:00 ET | Source: Nemaura Medical Inc

Nemaura Signs License and Distribution Agreement for SugarBEAT® Commercial Launch in Qatar

LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use by...
November 14, 2018 09:00 ET | Source: Nemaura Medical Inc

Nemaura Medical to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum

LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible continuous glucose monitor (CGM) for use by...
November 12, 2018 09:00 ET | Source: Nemaura Medical Inc

Nemaura Medical to Present at the Stifel 2018 Healthcare Conference

LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible continuous glucose monitor (CGM) for use by...
November 08, 2018 09:00 ET | Source: Nemaura Medical Inc

Nemaura Medical Inc. Reports Second Quarter 2018 Financial Results

LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible continuous glucose monitor (CGM) for use by...
November 07, 2018 09:00 ET | Source: Nemaura Medical Inc

Nemaura Successfully Develops Predictive Algorithms and Alarm Functionality for Continuous Glucose Monitor SugarBEAT®

LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible Continuous Glucose Monitor (CGM) for use by...
October 22, 2018 08:00 ET | Source: Nemaura Medical Inc

Nemaura to Host Investor Webinar on October 23rd 2018 to Provide Update on Recent Developments

LOUGHBOROUGH, England - Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible Continuous Glucose Monitor (CGM) for use by...
September 25, 2018 08:00 ET | Source: Nemaura Medical Inc

Nemaura Reports Positive Zero Finger-Stick Calibration Data for SugarBEAT® Continuous Glucose Monitor

LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible Continuous Glucose Monitor (CGM) for use by...
September 18, 2018 08:00 ET | Source: Nemaura Medical Inc

Nemaura Signs Letter of Intent for SugarBEAT® Commercial Launch in Qatar

LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible Continuous Glucose Monitor (CGM) for use by...